The use of propofol does not increase the cost of the management of patients in heart surgery with extracorporeal circulation

• Published in: Annales françaises d'anesthésie et de réanimation Vol. 19; no. 9; pp. 662 - 667
• Main Authors: Legendre, E, Gallais, S, Le Teurnier, Y, Iooss, P, Maupetit, J C, Blanloeil, Y
• Format: Journal Article
• Language: French
• Published: France 01.11.2000
• Subjects: Aged; Anesthetics, Intravenous - economics; Cardiopulmonary Bypass - economics; Case-Control Studies; Drug Costs; Female; France; Hospital Costs; Humans; Intensive Care Units - statistics & numerical data; Male; Propofol - economics; Prospective Studies; Retrospective Studies
• ISSN: 0750-7658; 1769-6623

Evaluation of the cost of propofol used for fast-track in cardiac surgery and its impact on global cost of management for anaesthesia and intensive care. Case-control study, prospective (1998) and retrospective (1994). Twenty patients operated for cardiac surgery in 1998 and scheduled for fast-track anaesthesia. Twenty patients in 1994 matched for different criteria to the patient of 1998. In 1998, all drugs, materials used and X-rays, biochemical assays performed were prospectively collected and their cost calculated. In 1994, similar calculations were done retrospectively. Comparison of duration of mechanical ventilation, hospitalization in intensive care and in the hospital were performed. Cost of anaesthesia was similar in 1994 and 1998 (2,646 FF versus 2,294 FF). Global cost of management was significantly lower in 1998 in comparison to 1994 (5,439 FF versus 8,558 FF). Duration of mechanical ventilation, hospitalization in intensive care and in the hospital were shorter in 1998 than in 1994. Despite a higher cost of propofol for anaesthesia and postoperative sedation in comparison to midazolam, the global cost of management decreased significantly in relation to a one day decrease in hospitalization in the intensive care unit.